Viral dynamics and anti-viral pharmacodynamics: rethinking in vitro measures of drug potency (Q34134880)

31 July 2017

1 reference

title

Viral dynamics and anti-viral pharmacodynamics: rethinking in vitro measures of drug potency (English)

1 reference

31 July 2017

1 reference

3

Anderson RM

1 reference

31 July 2017

1

Ferguson NM

1 reference

31 July 2017

Fraser C

2

1 reference

31 July 2017

1 February 2001

1 reference

Trends in Pharmacological Sciences

31 July 2017

1 reference

31 July 2017

22

1 reference

31 July 2017

97-100

1 reference

31 July 2017

2

1 reference

Virus dynamics and drug therapy

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901615-1

7 January 2021

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901615-1

7 January 2021

Antigen-driven CD4+ T cell and HIV-1 dynamics: residual viral replication under highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901615-1

7 January 2021

Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901615-1

7 January 2021

Persistence of HIV-1 Transcription in Peripheral-Blood Mononuclear Cells in Patients Receiving Potent Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901615-1

7 January 2021

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901615-1

7 January 2021

Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901615-1

7 January 2021

Human serum attenuates the activity of protease inhibitors toward wild-type and mutant human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901615-1

7 January 2021

Synergistic drug interactions of an HIV-1 protease inhibitor with AZT in different in vitro models of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901615-1

7 January 2021

Antagonism between human immunodeficiency virus type 1 protease inhibitors indinavir and saquinavir in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901615-1

7 January 2021

10.1016/S0165-6147(00)01615-1

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11166854